Home
Live Updates
FDA Approves First Drug to Treat Alzheimers Agitation : vimarsana.com
FDA Approves First Drug to Treat Alzheimer's Agitation
The antipsychotic brexpiprazole (Rexulti) is the first FDA-approved treatment option for agitation associated with Alzheimer's disease.
Related Keywords
Tiffany Farchione ,
Division Of Psychiatry ,
Lundbeck ,
Drug Administration ,
Drug Evaluation ,
Cohen Mansfield Agitation Inventory ,
Alzheimers Disease ,
Lzheimer Disease ,
Agitation ,
Dementia ,
Antipsychotics ,
Euroleptics ,
Euroleptic Drugs ,
Depression ,
Adverse Effects ,
Ide Effects ,
Aggression ,
Antidepressant ,
Ntidepressant Drug ,
Rug Antidepressant ,
Anxiety Disorder ,
Elderly Concerns Of Older Adults ,
Dizziness ,
Us Food And Drug Administration ,
Nited States Food And Drug Administration ,
Da ,
Geriatrics Elder Care ,
Headache ,
vimarsana.com © 2020. All Rights Reserved.